Antares Pharma Announces the Addition of Leonard S. Jacob, M.D., Ph.D. to the Board of Directors.EWING, N.J. -- Antares Pharma, Inc. (Amex:AIS) has elected Leonard S. Jacob, M.D., Ph.D. to the Company's Board of Directors. Dr. Leonard Jacob joins Antares with over 29 years of pharmaceutical industry experience including having founded InKine Pharmaceutical Company Inc. in 1997 and served as Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. from its founding until the company was acquired by Salix Pharmaceuticals in 2005. In 1989 Dr. Jacob co-founded Maganin Pharmaceuticals and served as its COO until 1996. From 1980 to 1989 Dr. Jacob served in a variety of executive roles including Worldwide Vice President of SmithKline & French Labs (now Glaxo-SmithKline) and as a member of their Corporate Management Committee. He earned a Ph.D. in pharmacology from Temple University and an M.D. from the Medical College of Pennsylvania Medical College of Pennsylvania, formerly in Philadelphia; chartered and opened 1850 as the Female Medical College of Pennsylvania; became Woman's Medical College of Pennsylvania 1867, Medical College of Pennsylvania 1970. (Drexel University College of Medicine Drexel University College of Medicine is the medical school of Drexel University. It represents the consolidation of two venerable medical schools: the nation's first medical school for women and the first U.S. college of homeopathy. Residency Locations St. ). Dr. Jacob currently serves as Chairman of Life Science Advisors, a consulting group to the healthcare industry and is non-executive Chairman of the Board of Bradley Pharmaceuticals, Inc., a specialty pharma company focused principally on niche physician specialty markets in the U.S. He also serves on the Board of the Colon Cancer Alliance Colon Cancer Alliance (CCA) is the largest colorectal cancer non-profit organization in the U.S., with over 37,000 members and more than a hundred chapters. The CCA is dedicated to reducing the suffering caused by colorectal cancer through patient support, education, research and and the Board of Overseers for Temple University School of Medicine The Temple University School of Medicine (TUSM), located on the Health Science Campus of Temple University in Philadelphia, PA, is one of 6 schools of medicine in Pennsylvania conferring the doctor of medicine (M.D.) degree. and is a founding Director of the Jacob Internet fund, a public mutual fund. Jack E. Stover stover stalks of maize plants from which mature corn cobs have been harvested as grain, or grain sorghum plants from which heads have also been removed. The stover is usually fed by turning the cattle into the field and is subject to fungal infection, sometimes causing mycotoxicosis. , President & CEO of Antares, stated, "We welcome Dr. Jacob to our Board of Directors and are pleased to be working with such a seasoned executive. His level of expertise and understanding of all aspects of our industry will be invaluable to Antares as we move forward with execution of our business plan as a specialty pharmaceutical company." About Antares Pharma Antares Pharma is a specialized pharma product development company focused on developing patented drug delivery systems and injectable device engineering capabilities. Antares' current technology platforms include its ATD ATD Anthropomorphic Test Dummy ATD Attention to Detail ATD Advanced Technology Demonstration AtD Achieving the Dream ATD Atmospheric Technology Division (US National Center for Atmospheric Research) ATD Assistant Technical Director [TM] Advanced Transdermal Delivery system transdermal delivery system: see skin patch. , and its related TecTix[TM] system for topical and transmucosal delivery, its Easy Tec[TM] oral fast-melt technology, and subcutaneous injection technology platforms including both Vibex[TM] disposable mini-needle injection device and Valeo[TM]/Vision[R] reusable needle-free injection devices. Antares Pharma is committed to leveraging its multiple drug delivery platforms to add value to existing drugs and to create new pharmaceutical products and injectable devices. Overall, Antares' product pipeline, if approved, will address unmet medical needs by reducing side effect profiles, improving safety, increasing effectiveness, and improving patient compliance and convenience. Antares Pharma has corporate headquarters in Princeton Crossroads Corporate Center in Ewing, NJ, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapolis, Minnesota and Basel, Switzerland. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion